Cargando…

Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis

BACKGROUND: Biomarkers are potentially useful in assessment of outcomes in patients with cirrhosis, but information is very limited. Given the large number of biomarkers, adequate choice of which biomarker(s) to investigate first is important. AIM: Analysis of potential usefulness of a panel of urin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ariza, Xavier, Solà, Elsa, Elia, Chiara, Barreto, Rogelio, Moreira, Rebeca, Morales-Ruiz, Manuel, Graupera, Isabel, Rodríguez, Ezequiel, Huelin, Patricia, Solé, Cristina, Fernández, Javier, Jiménez, Wladimiro, Arroyo, Vicente, Ginès, Pere
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456079/ https://www.ncbi.nlm.nih.gov/pubmed/26042740 http://dx.doi.org/10.1371/journal.pone.0128145

Ejemplares similares

Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis
por: Graupera, Isabel, et al.
Publicado: (2016)

Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis
por: Solé, Cristina, et al.
Publicado: (2016)

Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes
por: Graupera, Isabel, et al.
Publicado: (2017)

Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival
por: Solé, Cristina, et al.
Publicado: (2019)

Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study
por: Cárdenas, Andrés, et al.
Publicado: (2014)

Psychological Burden of Hepatic Encephalopathy on Patients and Caregivers
por: Fabrellas, Núria, et al.
Publicado: (2020)

Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure
por: Blaya, Delia, et al.
Publicado: (2021)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Patterns of kidney dysfunction in acute‐on‐chronic liver failure: Relationship with kidney and patients’ outcome
por: Napoleone, Laura, et al.
Publicado: (2022)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Effects of the COVID-19 pandemic on the activity of an advanced practice nurse clinic on liver cirrhosis
por: Perez, Martina, et al.
Publicado: (2022)

Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
por: Graupera, Isabel, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosis
por: Rivera-Esteban, Jesús, et al.
Publicado: (2022)

Acute-on-chronic liver failure: an update
por: Hernaez, Ruben, et al.
Publicado: (2017)

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival
por: Kerbert, Annarein J. C., et al.
Publicado: (2017)

Prognostic Markers in Patients with Cirrhosis and Portal Hypertension Who Have Not Bled
por: Poca, Maria, et al.
Publicado: (2011)

A salivary biomarker panel to detect liver cirrhosis
por: Trevisan França de Lima, Lucas, et al.
Publicado: (2023)

High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study
por: Bassegoda, Octavi, et al.
Publicado: (2022)

Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study
por: Fabrellas, Núria, et al.
Publicado: (2018)

Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life
por: Carol, Marta, et al.
Publicado: (2022)

Serum and urinary metabolomics and outcomes in cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Genomic Signature in Evolutionary Biology: A Review
por: de la Fuente, Rebeca, et al.
Publicado: (2023)

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
por: Pose, Elisa, et al.
Publicado: (2021)

Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
por: Li, Hai, et al.
Publicado: (2016)

Review of Defective NADPH Oxidase Activity and Myeloperoxidase Release in Neutrophils From Patients With Cirrhosis
por: Moreau, Richard, et al.
Publicado: (2019)

Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis
por: Trebicka, Jonel, et al.
Publicado: (2019)

Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders
por: Fortea, José Ignacio, et al.
Publicado: (2020)

Urinary Biomarkers of Acute Kidney Injury in Patients with Liver Cirrhosis
por: Qasem, Anass Ahmed, et al.
Publicado: (2014)

Urinary Biomarkers of Acute Kidney Injury in Patients With Liver Cirrhosis
por: Ahmed, Qasem Anass, et al.
Publicado: (2014)

Urinary marker panels for aggressive prostate cancer detection
por: Lih, Tung-Shing Mamie, et al.
Publicado: (2022)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
por: Llibre-Nieto, Gemma, et al.
Publicado: (2021)

Utility of Urinary Neutrophil Gelatinase Associated Lipocalin (NGAL) in Decompensated Cirrhosis
por: Krishna Reddy, S Sai, et al.
Publicado: (2020)

Urinary Neuropilin-1: A Predictive Biomarker for Renal Outcome in Lupus Nephritis
por: Torres-Salido, Maria Teresa, et al.
Publicado: (2019)

Urinary mRNA biomarker panel for the detection of urothelial carcinoma
por: Urquidi, Virginia, et al.
Publicado: (2016)

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders
por: Chen, Jian-jun, et al.
Publicado: (2018)

Urinary peptide panel for prognostic assessment of bladder cancer relapse
por: Krochmal, Magdalena, et al.
Publicado: (2019)

Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis
por: Affò, Silvia, et al.
Publicado: (2015)

Conoce a tus hijos : tests de 7 a 12 años /
por: Price Huelin, Beatriz
Publicado: (2005)

An increased risk of urinary tract infection precedes development of primary biliary cirrhosis
por: Varyani, Fumi K, et al.
Publicado: (2011)

Analysis of a Urinary Biomarker Panel for Obstructive Nephropathy and Clinical Outcomes
por: Xie, Yuanyuan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_75m60tmqdrvkuulfupjc1uvhta